Nordic Life Science 1
42 “With the technology developed in Sweden, we n
ow have the possibility to anchor a titanium implant in the short remaining skeleton that exits through the skin and acts as a perfect anchoring point for a prosthetic device.” O n the first day, we treat two patients with very short remaining arm stumps of less than ten centimeters. On the second day, we treat two leg patients. The last patient has almost no femur left but by using advanced surgical principles we are able to move some bone from the iliac crest, part of the pelvic bone, to the end of the remaining femur, and thereby add length so we can anchor an implant and give him the possibility to walk again. Vlad is a very skilled surgeon, and it's relatively easy for him to keep up with the procedures that we are doing together. Soon he will be able to do this independently and he will also be able to train others in Ukraine, because with those more than 100,000 amputees we really need Rickard Brånemark, Chief Medical and Scientific Officer, Integrum to scale up the chances of bringing people out of wheelchairs and back to a normal life again. We have treated about a hundred patients in Ukraine so far. Given the more than a hundred thousand amputees, the enormity of what lies ahead is clear. Once we have finished with the operations I head towards Kyiv, that's where all the important political decision makers are. This treatment is new to Ukraine, and the politicians are still discussing whether they are prepared to reimburse it. They have already decided to reimburse external prosthetic components but not the internal implants yet. In Kyiv, I meet up with influential orthopedic surgeons and politicians, I also attend seminars and a small press conference. A fter Kyiv, I head to Lviv. It's about a six-hour drive on roads full of potholes. I meet up with a very interesting organization called Superhumans, a non-profit organization created originally by Ukrainians and heavily supported by the Buffett family. All patients are treated for free, and the focus is on amputees. Superhumans mainly use the traditional socket technology but they have invested in operating room capabilities and now they are interested in learning more about the implant technology we are bringing to Ukraine. This is the eighth time I've been in Ukraine. What still strikes me is how, despite the war, the country runs more or less business as usual – with the exception of the healthcare system, which is carrying an enormous burden of wounded soldiers. For the Nordic life science industry there is both a humanitarian need and a real business opportunity here, not only in advanced implant care for amputees but also in hygiene and infection control, where companies like Mölnlycke Healthcare should be able to make a difference. The technology exists. Ukraine needs it. The question is how quickly we can scale it up. NLS UKRAINE // CLINICAL TRAINING PHOTO DINA SOLDIN